drugset / Trial / NCT00097448

Sudden Deafness Treatment Trial

NCT00097448

RandomizedParallel-groupOpen-labelTreatment

Summary

This trial aims to compare the efficacy of oral prednisone vs. methylprednisolone injected into the middle ear for the treatment of moderate-to-severe, sudden sensorineural hearing loss (inner ear hearing loss affecting one ear that occurs over less than 72 hours).

Timeline

Start
2004-12
Primary completion
2009-10
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylprednisolone Other / unclassified 40 mg/ml Other
Subject Prednisone Other / unclassified 60 mg Oral